Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.

The global Cell and Gene Therapy Drug Delivery Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Drug Delivery Devices.

Report Scope

The Cell and Gene Therapy Drug Delivery Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell and Gene Therapy Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell and Gene Therapy Drug Delivery Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cell and Gene Therapy Drug Delivery Devices Market Report

Report Metric	Details
Report Name	Cell and Gene Therapy Drug Delivery Devices Market
CAGR	5%
Segment by Type	Sterile Insulin Syringe Pre-Filled Syringe Infusion Bags
Segment by Application	Luxturna Kymriah Provenge Zolgensma Yescarta Strimvelis
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Drug Delivery Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Gene Therapy Drug Delivery Devices Market report?

Ans: The main players in the Cell and Gene Therapy Drug Delivery Devices Market are Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation

What are the Application segmentation covered in the Cell and Gene Therapy Drug Delivery Devices Market report?

Ans: The Applications covered in the Cell and Gene Therapy Drug Delivery Devices Market report are Luxturna, Kymriah, Provenge, Zolgensma, Yescarta, Strimvelis

What are the Type segmentation covered in the Cell and Gene Therapy Drug Delivery Devices Market report?

Ans: The Types covered in the Cell and Gene Therapy Drug Delivery Devices Market report are Sterile Insulin Syringe, Pre-Filled Syringe, Infusion Bags

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Sterile Insulin Syringe

1.2.3 Pre-Filled Syringe

1.2.4 Infusion Bags

1.3 Market by Application

1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Luxturna

1.3.3 Kymriah

1.3.4 Provenge

1.3.5 Zolgensma

1.3.6 Yescarta

1.3.7 Strimvelis

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2019-2030)

2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Region

2.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Region (2019-2024)

2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2025-2030)

2.3 Cell and Gene Therapy Drug Delivery Devices Market Dynamics

2.3.1 Cell and Gene Therapy Drug Delivery Devices Industry Trends

2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers

2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges

2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue

3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2019-2024)

3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2019-2024)

3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue

3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio

3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2023

3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served

3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service

3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type

4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2019-2024)

4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2025-2030)

5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application

5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2019-2024)

5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)

6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024)

6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)

7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024)

7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)

8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2019-2024)

8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)

9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024)

9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)

10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024)

10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen, Inc.

11.1.1 Amgen, Inc. Company Detail

11.1.2 Amgen, Inc. Business Overview

11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.1.5 Amgen, Inc. Recent Development

11.2 Bausch and Lomb Incorporated

11.2.1 Bausch and Lomb Incorporated Company Detail

11.2.2 Bausch and Lomb Incorporated Business Overview

11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction

11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.2.5 Bausch and Lomb Incorporated Recent Development

11.3 Becton, Dickinson and Company

11.3.1 Becton, Dickinson and Company Company Detail

11.3.2 Becton, Dickinson and Company Business Overview

11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction

11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.3.5 Becton, Dickinson and Company Recent Development

11.4 Bluebird bio, Inc.

11.4.1 Bluebird bio, Inc. Company Detail

11.4.2 Bluebird bio, Inc. Business Overview

11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.4.5 Bluebird bio, Inc. Recent Development

11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)

11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Detail

11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview

11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction

11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development

11.6 Dendreon Pharmaceuticals LLC.

11.6.1 Dendreon Pharmaceuticals LLC. Company Detail

11.6.2 Dendreon Pharmaceuticals LLC. Business Overview

11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction

11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.6.5 Dendreon Pharmaceuticals LLC. Recent Development

11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)

11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Detail

11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview

11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction

11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development

11.8 Human Stem Cell Institute

11.8.1 Human Stem Cell Institute Company Detail

11.8.2 Human Stem Cell Institute Business Overview

11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction

11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.8.5 Human Stem Cell Institute Recent Development

11.9 Kite Pharma, Inc.

11.9.1 Kite Pharma, Inc. Company Detail

11.9.2 Kite Pharma, Inc. Business Overview

11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.9.5 Kite Pharma, Inc. Recent Development

11.10 Kolon Tissue Gene, inc.

11.10.1 Kolon Tissue Gene, inc. Company Detail

11.10.2 Kolon Tissue Gene, inc. Business Overview

11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.10.5 Kolon Tissue Gene, inc. Recent Development

11.11 Novartis AG

11.11.1 Novartis AG Company Detail

11.11.2 Novartis AG Business Overview

11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction

11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.11.5 Novartis AG Recent Development

11.12 Orchard Therapeutics plc.

11.12.1 Orchard Therapeutics plc. Company Detail

11.12.2 Orchard Therapeutics plc. Business Overview

11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.12.5 Orchard Therapeutics plc. Recent Development

11.13 Pfizer, Inc.

11.13.1 Pfizer, Inc. Company Detail

11.13.2 Pfizer, Inc. Business Overview

11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.13.5 Pfizer, Inc. Recent Development

11.14 Renova Therapeutics

11.14.1 Renova Therapeutics Company Detail

11.14.2 Renova Therapeutics Business Overview

11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction

11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.14.5 Renova Therapeutics Recent Development

11.15 Spark Therapeutics, Inc.

11.15.1 Spark Therapeutics, Inc. Company Detail

11.15.2 Spark Therapeutics, Inc. Business Overview

11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.15.5 Spark Therapeutics, Inc. Recent Development

11.16 uniQure N.V.

11.16.1 uniQure N.V. Company Detail

11.16.2 uniQure N.V. Business Overview

11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction

11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.16.5 uniQure N.V. Recent Development

11.17 Vericel Corporation

11.17.1 Vericel Corporation Company Detail

11.17.2 Vericel Corporation Business Overview

11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction

11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

11.17.5 Vericel Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Amgen Inc

Bausch and Lomb Incorporated

Becton Dickinson and Company

bluebird bio Inc

Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)

Dendreon Pharmaceuticals LLC.

Helixmith Co., Ltd (ViroMed Co., Ltd)

Human Stem Cell Institute

Kite Pharma Inc.

Kolon Tissue Gene, inc.

Novartis

Orchard Therapeutics plc.

Pfizer Inc

RENOVA THERAPEUTICS

Spark Therapeutics Inc

uniQure N.V.

Vericel Corporation

List of Tables

Table 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Sterile Insulin Syringe

Table 3. Key Players of Pre-Filled Syringe

Table 4. Key Players of Infusion Bags

Table 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2019-2024)

Table 9. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2025-2030)

Table 11. Cell and Gene Therapy Drug Delivery Devices Market Trends

Table 12. Cell and Gene Therapy Drug Delivery Devices Market Drivers

Table 13. Cell and Gene Therapy Drug Delivery Devices Market Challenges

Table 14. Cell and Gene Therapy Drug Delivery Devices Market Restraints

Table 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players (2019-2024)

Table 17. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2023)

Table 18. Ranking of Global Top Cell and Gene Therapy Drug Delivery Devices Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service

Table 22. Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2019-2024)

Table 26. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2025-2030)

Table 28. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2019-2024)

Table 30. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2025-2030)

Table 32. North America Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2025-2030) & (US$ Million)

Table 47. Amgen, Inc. Company Detail

Table 48. Amgen, Inc. Business Overview

Table 49. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product

Table 50. Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 51. Amgen, Inc. Recent Development

Table 52. Bausch and Lomb Incorporated Company Detail

Table 53. Bausch and Lomb Incorporated Business Overview

Table 54. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product

Table 55. Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 56. Bausch and Lomb Incorporated Recent Development

Table 57. Becton, Dickinson and Company Company Detail

Table 58. Becton, Dickinson and Company Business Overview

Table 59. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product

Table 60. Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 61. Becton, Dickinson and Company Recent Development

Table 62. Bluebird bio, Inc. Company Detail

Table 63. Bluebird bio, Inc. Business Overview

Table 64. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product

Table 65. Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 66. Bluebird bio, Inc. Recent Development

Table 67. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Detail

Table 68. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview

Table 69. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product

Table 70. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 71. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development

Table 72. Dendreon Pharmaceuticals LLC. Company Detail

Table 73. Dendreon Pharmaceuticals LLC. Business Overview

Table 74. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product

Table 75. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 76. Dendreon Pharmaceuticals LLC. Recent Development

Table 77. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Detail

Table 78. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview

Table 79. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product

Table 80. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 81. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development

Table 82. Human Stem Cell Institute Company Detail

Table 83. Human Stem Cell Institute Business Overview

Table 84. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product

Table 85. Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 86. Human Stem Cell Institute Recent Development

Table 87. Kite Pharma, Inc. Company Detail

Table 88. Kite Pharma, Inc. Business Overview

Table 89. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product

Table 90. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 91. Kite Pharma, Inc. Recent Development

Table 92. Kolon Tissue Gene, inc. Company Detail

Table 93. Kolon Tissue Gene, inc. Business Overview

Table 94. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product

Table 95. Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 96. Kolon Tissue Gene, inc. Recent Development

Table 97. Novartis AG Company Detail

Table 98. Novartis AG Business Overview

Table 99. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product

Table 100. Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 101. Novartis AG Recent Development

Table 102. Orchard Therapeutics plc. Company Detail

Table 103. Orchard Therapeutics plc. Business Overview

Table 104. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product

Table 105. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 106. Orchard Therapeutics plc. Recent Development

Table 107. Pfizer, Inc. Company Detail

Table 108. Pfizer, Inc. Business Overview

Table 109. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product

Table 110. Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 111. Pfizer, Inc. Recent Development

Table 112. Renova Therapeutics Company Detail

Table 113. Renova Therapeutics Business Overview

Table 114. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product

Table 115. Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 116. Renova Therapeutics Recent Development

Table 117. Spark Therapeutics, Inc. Company Detail

Table 118. Spark Therapeutics, Inc. Business Overview

Table 119. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product

Table 120. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 121. Spark Therapeutics, Inc. Recent Development

Table 122. uniQure N.V. Company Detail

Table 123. uniQure N.V. Business Overview

Table 124. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product

Table 125. uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 126. uniQure N.V. Recent Development

Table 127. Vericel Corporation Company Detail

Table 128. Vericel Corporation Business Overview

Table 129. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product

Table 130. Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024) & (US$ Million)

Table 131. Vericel Corporation Recent Development

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type: 2023 VS 2030

Figure 3. Sterile Insulin Syringe Features

Figure 4. Pre-Filled Syringe Features

Figure 5. Infusion Bags Features

Figure 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2023 VS 2030

Figure 8. Luxturna Case Studies

Figure 9. Kymriah Case Studies

Figure 10. Provenge Case Studies

Figure 11. Zolgensma Case Studies

Figure 12. Yescarta Case Studies

Figure 13. Strimvelis Case Studies

Figure 14. Cell and Gene Therapy Drug Delivery Devices Report Years Considered

Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region: 2023 VS 2030

Figure 18. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players in 2023

Figure 19. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2023

Figure 21. North America Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2019-2030)

Figure 23. United States Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2019-2030)

Figure 27. Germany Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2019-2030)

Figure 35. China Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2019-2030)

Figure 43. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2019-2030)

Figure 47. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Amgen, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 50. Bausch and Lomb Incorporated Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 51. Becton, Dickinson and Company Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 52. Bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 53. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 54. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 55. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 56. Human Stem Cell Institute Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 57. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 58. Kolon Tissue Gene, inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 59. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 60. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 61. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 62. Renova Therapeutics Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 63. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 64. uniQure N.V. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 65. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions